These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 31205266

  • 21. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J.
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 24. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
    Fidler S, Swaminathan R, Lim W, Ferrari P, Witt C, Christiansen FT, D'Orsogna LJ, Irish AB.
    Transpl Immunol; 2013 Dec 27; 29(1-4):22-7. PubMed ID: 24090807
    [Abstract] [Full Text] [Related]

  • 25. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J.
    Transplant Proc; 2011 Dec 27; 43(6):2154-6. PubMed ID: 21839219
    [Abstract] [Full Text] [Related]

  • 26. The 37-year kidney transplantation experience at Siriraj Hospital.
    Premasathian N, Vongwiwatana A, Taweemonkongsap T, Amornvesukit T, Limsrichamrern S, Jitpraphai S, Kositamongkol P, Mahawithitwong P, Sritippayawan S, Chanchairujira T, Nualyong C, Vareesangthip K, Vasuvattakul S, Sirivatanauksorn Y.
    Clin Transpl; 2010 Dec 27; ():141-8. PubMed ID: 21696037
    [Abstract] [Full Text] [Related]

  • 27. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
    Goh A, Oei E, Vathsala A.
    Transplant Proc; 2012 Jan 27; 44(1):193-9. PubMed ID: 22310613
    [Abstract] [Full Text] [Related]

  • 28. Human Leukocyte Antigen Compatibility and De Novo Donor-Specific Antibodies in Long-term Renal Transplant Patients With Stable Graft Function.
    Kasimatis E, Fylaktou A, Karampatakis T, Schoina M, Zarras C, Anastasiou A, Papachristou M, Boukla A, Daoudaki M, Fouzas I, Papagianni A.
    Transplant Proc; 2019 Mar 27; 51(2):413-415. PubMed ID: 30879554
    [Abstract] [Full Text] [Related]

  • 29. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun 27; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 30. Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure.
    Khovanova N, Daga S, Shaikhina T, Krishnan N, Jones J, Zehnder D, Mitchell D, Higgins R, Briggs D, Lowe D.
    Transpl Int; 2015 Dec 27; 28(12):1405-15. PubMed ID: 26264744
    [Abstract] [Full Text] [Related]

  • 31. Kidneys From Deceased Elderly Donors: Factors Associated With Adverse Outcomes.
    Adekoya AO, Halawa A.
    Exp Clin Transplant; 2016 Feb 27; 14(1):32-7. PubMed ID: 26862822
    [Abstract] [Full Text] [Related]

  • 32. A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.
    Rebellato LM, Everly MJ, Haisch CE, Ozawa M, Briley KP, Parker K, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC.
    Clin Transpl; 2011 Feb 27; ():337-40. PubMed ID: 22755428
    [Abstract] [Full Text] [Related]

  • 33. Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation.
    Rebellato LM, Parker K, Everly MJ, Briley KP, Kendrick W, Kendrick S, Haisch CE, Terasaki PI, Bolin P.
    Clin Transpl; 2014 Feb 27; ():137-42. PubMed ID: 26281138
    [Abstract] [Full Text] [Related]

  • 34. Prevalence and impact of HLA and MICA allele mismatching on donor-specific antibodies induction in kidney transplant rejection.
    Romphruk AV, Simtong P, Suntornnipat J, Sudwilai Y, Cheunta S, Chan-On C, Leelayuwat C.
    Nephrology (Carlton); 2021 Oct 27; 26(10):833-841. PubMed ID: 34197005
    [Abstract] [Full Text] [Related]

  • 35. Frequency of Human Leukocyte Antigens and Donor Specific Antibodies in Long-Term Living Donor Kidney Transplantation.
    Alagoz S, Seyahi N.
    Transplant Proc; 2019 Sep 27; 51(7):2302-2307. PubMed ID: 31358448
    [Abstract] [Full Text] [Related]

  • 36. Association Between Delayed Graft Function and Graft Loss in Donation After Cardiac Death Kidney Transplants-A Paired Kidney Registry Analysis.
    Lim WH, McDonald SP, Russ GR, Chapman JR, Ma MK, Pleass H, Jaques B, Wong G.
    Transplantation; 2017 Jun 27; 101(6):1139-1143. PubMed ID: 28538652
    [Abstract] [Full Text] [Related]

  • 37. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, McDiarmid SV, Reed EF.
    Transplantation; 2015 Jul 27; 99(7):1416-22. PubMed ID: 26038872
    [Abstract] [Full Text] [Related]

  • 38. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Jul 27; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 39. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
    Süsal C, Wettstein D, Döhler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Živčić-Ćosić S, Balen S, Weimer R, Slavcev A, Bösmüller C, Norman DJ, Zeier M, Opelz G, Collaborative Transplant Study Report.
    Transplantation; 2015 Sep 27; 99(9):1976-80. PubMed ID: 25769065
    [Abstract] [Full Text] [Related]

  • 40. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE, Weng RR, Piper M, Laugenou K, Ichii H, Lakey J, Malinoski D.
    Transplant Proc; 2012 Jan 27; 44(1):164-6. PubMed ID: 22310605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.